BiopharmaTrend: Where Tech Meets Bio

BioPharmaTrend

#advertisement

ThermoFisher Scientific: Integrated genetic technologies for cell therapy development

Latest News

Potential Breakthrough in Cell Reprogramming as OpenAI …

Potential Breakthrough in Cell Reprogramming as OpenAI and Retro Biosciences Report 50x Pluripotency Marker Expression Gains

OpenAI and Retro Biosciences have released new findings from a joint effort in AI-driven protein engineering. Using GPT-4b micro, a biology-specialized variant of GPT-4o, the … Read More

Immunai Opens Free Single-Cell Sequencing Program for …

Immunai Opens Free Single-Cell Sequencing Program for Academic Labs

Immunai, a New York–based company specializing in AI-driven immune system mapping, has announced a program offering academic researchers free access to its single-cell immune profiling … Read More

KYORIN Pharmaceutical Adopts AI Drug Discovery Platform …

KYORIN Pharmaceutical Adopts AI Drug Discovery Platform From Elix

KYORIN Pharmaceutical has adopted Elix Discovery, an AI-based drug discovery platform developed by Tokyo-based Elix. The system is designed to accelerate early-stage research by applying … Read More

Innovatrix and Opyl Partner to Launch AI-Driven Insurance for Clinical Trial Failure

Ginkgo, Inductive Bio, and Tangible Scientific Connect AI Models with Automated Labs for Drug Discovery

Silicon Valley’s Molecular Devices Brings AI to Brain Organoid Culture

Owkin to Bring Agentic AI into Vienna’s Oncology Ecosystem

Generative AI Designs Novel Antibiotics Against MRSA and Drug-Resistant Gonorrhea

BioAge Labs Begins Phase 1 Trial of Oral NLRP3 Inhibitor for Obesity

Read latest news ›››

Latest Insights

Into the Unknown — How Artificial Intelligence …

by Louise von Stechow

Into the Unknown — How Artificial Intelligence Can Help Biotech Companies Chart the Dark Genome

With DeepMind’s release of AlphaGenome—a deep learning model that can predict the relevance of variants in both coding and non-coding DNA—the so-called “dark genome” has … Read More

Into the Unknown — How Artificial Intelligence …

by Louise von Stechow

Into the Unknown — How Artificial Intelligence Can Help Biotech Companies Chart the Dark Genome

With DeepMind’s release of AlphaGenome—a deep learning model that can predict the relevance of variants in both coding and non-coding DNA—the so-called “dark genome” has … Read More

How AI Is Transforming Medicinal Chemistry Between Discovery and Manufacture

by Andrii Buvailo, PhD

"AI Scientists" - New Collaborators for Rare Disease Research?

by Louise von Stechow

What are Foundation Models in Biology and Healthcare?

by BiopharmaTrend

The Pivotal Role of AI in Clinical Trials: From Digital Twins to Synthetic Control Arms

by BiopharmaTrend

Building AI Solutions for Life Sciences and Healthcare

by BiopharmaTrend

Into the Unknown — How Artificial Intelligence Can Help Biotech Companies Chart the Dark Genome

by Louise von Stechow

Beyond Legacy Tools: Defining Modern AI Drug Discovery for 2025 and Beyond

by Andrii Buvailo, PhD, Oleg Kucheriavyi, PhD

AI-Based Next-Generation-Phenotyping for Rare Disease Diagnosis

by Adele Ruder, Alexander Hustinx, Louise von Stechow

Read all insights ›››

#advertisement

How BenchSci’s ASCEND Builds a Map for Biomedical Reasoning

From Our Partners

Read All ›››

Patented AI Platform Identifies Promising Early-Stage BioPharma …

Sponsored by Intelligencia AI

Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies

Chemistry CROs at a Crossroads: How SpiroChem …

Sponsored by SpiroChem

Chemistry CROs at a Crossroads: How SpiroChem Is Adapting to Market Shifts in 2025 and Beyond

AI Is Key to Democratizing Drug Discovery

Sponsored by OPTIC

AI Is Key to Democratizing Drug Discovery

Navigating the Crossroads of AI and Oncology: …

Sponsored by Lantern Pharma

Navigating the Crossroads of AI and Oncology: A Deep Dive with Lantern Pharma's CEO, Panna Sharma

Partner Events

View all events ›››

22nd BioPharma Drug Discovery Nexus Conference Belgium

22nd BioPharma Drug Discovery Nexus Conference Belgium

Event Date: April 29, 2026 - April 29, 2026

Location: Belgium (Brussels, Holiday Inn)

Website: Link

Interactive Response Technologies 2025

Interactive Response Technologies 2025

Event Date: Oct. 14, 2025 - Oct. 15, 2025

Location: United States of America (The Westin Copley Place, Boston, MA)

Website: Link

RNA Leaders USA Congress

RNA Leaders USA Congress

Event Date: Sept. 10, 2025 - Sept. 11, 2025

Location: United States of America (Boston Exhibition & Convention Center)

Website: Link

Drug Discovery Innovation Programme

Drug Discovery Innovation Programme

Event Date: Sept. 25, 2025 - Sept. 26, 2025

Location: Spain (InterContinental Barcelona, Spain)

Website: Link

KOREA LIFESCIENCE WEEK

KOREA LIFESCIENCE WEEK

Event Date: Oct. 30, 2025 - Nov. 1, 2025

Location: South Korea (coex, SEOUL)

Website: Link

Case Studies

Read All ›››

From Data to Discovery: How BenchSci’s ASCEND …

Sponsored by BenchSci

From Data to Discovery: How BenchSci’s ASCEND Builds a Map for Biomedical Reasoning

Revolutionizing Clinical Trials: How AI and Automation …

Sponsored by Trialize

Revolutionizing Clinical Trials: How AI and Automation Reduced Study Build Time from Months to Days

AI Becomes a Drop-in Replacement for Docking

Sponsored by RECEPTOR.AI

AI Becomes a Drop-in Replacement for Docking

Busting the PoseBusters v3: AI Docking Software …

Sponsored by RECEPTOR.AI

Busting the PoseBusters v3: AI Docking Software ArtiDock Beats Industry’s State of the Art in Speed and Accuracy

ArtiDock from Receptor.AI: Next-generation AI Docking That …

Sponsored by RECEPTOR.AI

ArtiDock from Receptor.AI: Next-generation AI Docking That Beats DiffDock and AlphaFold-latest

Powering Cancer Drug Discovery and Development Using …

Sponsored by Lantern Pharma

Powering Cancer Drug Discovery and Development Using the Artificial Intelligence and Machine Learning Platform RADR®

Using End-to-End Wet Lab Automation Combined with …

Sponsored by Arctoris

Using End-to-End Wet Lab Automation Combined with Machine Learning to Industrialize Drug Discovery

Identifying High Impact Tissue Sparing E3 Ligases …

Sponsored by Kymera Therapeutics

Identifying High Impact Tissue Sparing E3 Ligases and Their Binders

Interviews

Read All ›››

Navigating the Crossroads of AI and Oncology: …

Navigating the Crossroads of AI and Oncology: A Deep Dive with Lantern Pharma's CEO, Panna Sharma

This South Korean Company is at the …

This South Korean Company is at the Forefront of AI-driven Drug Discovery

Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs …

Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs and Precision Medicine in Oncology

Merging AI and Quantum Computing To Boost …

Merging AI and Quantum Computing To Boost Drug Discovery

Most Read

From Gene Editing to Pathway Design: How …

Artificial Intelligence

From Gene Editing to Pathway Design: How AI is Transforming Synthetic Biology

Insilico Medicine’s Generative AI Patent Provides Advantage …

Artificial Intelligence

Insilico Medicine’s Generative AI Patent Provides Advantage in AI Drug Discovery Race

17 Companies Building the Future of Drug …

--

17 Companies Building the Future of Drug Development on a Chip

Top AI in Pharma and Healthcare Conferences …

Artificial Intelligence

Top AI in Pharma and Healthcare Conferences in 2024 You Can’t Miss